Endocardial fibroelastosis: myocardial and vascular alterations associated with viral-like nuclear particles

American Heart Journal
|December 1, 1978
PubMed

Insights

This study presents the first evidence of viral myocarditis in endocardial fibroelastosis (EFE), identifying viral-like particles and vascular changes. These findings support a viral cause for EFE and suggest vascular occlusion is key to its development.

Area of Science:

  • Pathology
  • Virology
  • Cardiology

Background:

  • Endocardial fibroelastosis (EFE) is a condition of the heart's inner lining, with its infectious etiology debated.
  • Previous studies lacked definitive viral evidence or specific features of viral myocarditis in EFE.

Observation:

  • This case details a patient with EFE exhibiting chronic myocardial inflammation, fibrosis, and degenerative changes.
  • Ultrastructural analysis revealed abnormalities consistent with viral myocarditis, including endothelial cell proliferation and viral-like particles in myocardial and endothelial nuclei.
  • Similar pathological features were observed in skeletal muscle, further supporting an infectious origin.

Findings:

  • The study provides the first morphological evidence linking viral myocarditis to EFE.
  • Viral-like particles were identified within myocardial and endothelial cell nuclei.
  • Significant vascular occlusion within the myocardium was noted, potentially contributing to EFE pathogenesis.

Implications:

  • This research strengthens the hypothesis of a viral etiology for endocardial fibroelastosis.
  • The findings suggest that viral-induced vascular changes, particularly occlusion, may play a critical role in the development of EFE.
  • Further investigation into viral infections as a cause of EFE is warranted.

Related Concept Videos

Layers of the Heart Wall01:15

Layers of the Heart Wall

The heart wall comprises three distinct layers: the epicardium, myocardium, and endocardium. The outermost layer, the epicardium, is the visceral layer of the serous pericardium, featuring a thin, transparent mesothelial surface and an inner layer of areolar connective tissue with fat deposits that increase with age.
The myocardium, the thickest layer, consists of cardiac muscle cells interconnected by intercalated discs and crisscrossing connective tissue fibers. These muscle fibers contract...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...